SECTOR
Lasa Supergenerics expands manufacturing capacity of API Albendazole
Apr-25-2025

Lasa Supergenerics has expanded its manufacturing capacity for Albendazole USP. This enhancement was achieved through strategic debottlenecking of existing infrastructure and the installation of new machinery at its manufacturing facility.

This expansion strengthens the company’s ability to meet increasing demand for Albendazole across domestic and international markets, reaffirming its position as a trusted supplier of highquality Active Pharmaceutical Ingredients (APIs), The Expansion will further achieve Increased Capacity of Albendazole USP, Improve Product Efficiency and reduce lead time, enhance global supply capacity with adherence to top-tier quality and standards.

With the said Expansion the Total capacity is anticipated to represent a growth of 20%. This expansion is supported by a capital investment (CAPEX) of nearly Rs 1 crore which is already deployed and additional will be deployed over the time.

Lasa Supergenerics is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India.


  RELATED NEWS >>